Stereotactic ablative radiotherapy for the comprehensive treatment of 1-3 Oligometastatic tumors (SABR-COMET-3): study protocol for a randomized phase III trial.
Olson R, Mathews L, Liu M, Schellenberg D, Mou B, Berrang T, Harrow S, Correa RJM, Bhat V, Pai H, Mohamed I, Miller S, Schneiders F, Laba J, Wilke D, Senthi S, Louie AV, Swaminath A, Chalmers A, Gaede S, Warner A, de Gruijl TD, Allan A, Palma DA.
Olson R, et al. Among authors: bhat v.
BMC Cancer. 2020 May 5;20(1):380. doi: 10.1186/s12885-020-06876-4.
BMC Cancer. 2020.
PMID: 32370765
Free PMC article.